Skip to main content
Top

Open Access 08-04-2024 | Urothelial Cancer | Kidneys, Ureters, Bladder, Retroperitoneum

CT and MRI findings of small cell neuroendocrine carcinoma of the urinary bladder: comparison with urothelial carcinoma

Authors: Masaya Kawaguchi, Hiroki Kato, Takuya Koie, Yoshifumi Noda, Fuminori Hyodo, Tatsuhiko Miyazaki, Masayuki Matsuo

Published in: Abdominal Radiology

Login to get access

Abstract

Objective

This study aimed to evaluate the efficacy of CT and MRI findings to differentiate small cell neuroendocrine carcinoma (SCNEC) from urothelial carcinoma (UC) of the urinary bladder.

Materials and methods

This study included 90 patients with histopathologically confirmed bladder cancer (10 SCNECs and 80 UCs). Eight patients with bladder SCNEC and 80 with UC underwent CT and MRI, whereas the remaining two patients with SCNEC underwent CT alone before treatment. CT and MRI findings were retrospectively evaluated and compared between the two pathologies.

Results

The maximum diameter (36.5 mm vs. 19.0 mm, p < 0.01) and height (22.0 mm vs. 14.0 mm, p < 0.01) of the tumor in bladder SCNEC were higher than in UC. The pedunculated configuration (20% vs. 61%, p < 0.05) and irregular tumor margins (20% vs. 76%, p < 0.01) in bladder SCNEC were less common than in UC. The CT attenuation of the solid component in unenhanced CT images was higher in bladder SCNEC than in UC (37 Hounsfield unit [HU] vs. 34 HU, p < 0.01). The apparent diffusion coefficient (ADC) of the solid component in bladder SCNEC was lower than in UC (0.49 × 10−3 mm2/s vs. 1.02 × 10−3 mm2/s, p < 0.01).

Conclusion

In comparison with UC, bladder SCNEC was larger, had higher unenhanced CT attenuation, and had a lower ADC value. The pedunculated configuration and irregular tumor margins were typical of bladder UC.

Graphical abstract

Literature
1.
go back to reference de Krijger R, Fine S, Lotan T, Ro J, Rubin M, Wei Q (2022) Small cell neuroendocrine carcnoma. WHO classification of Urinary and Male Genital Tumours, 5th ed, vol 8 Lyon, France: IARC Press.389-391. de Krijger R, Fine S, Lotan T, Ro J, Rubin M, Wei Q (2022) Small cell neuroendocrine carcnoma. WHO classification of Urinary and Male Genital Tumours, 5th ed, vol 8 Lyon, France: IARC Press.389-391.
10.
go back to reference Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ (2010) Neuroendocrine tumor of the bladder. Rev Urol. 12(4):e197-201.PubMedPubMedCentral Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ (2010) Neuroendocrine tumor of the bladder. Rev Urol. 12(4):e197-201.PubMedPubMedCentral
13.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. 33(1):159-174.CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. 33(1):159-174.CrossRefPubMed
20.
go back to reference Williamson S, Al-Ahmadie H, Chang L, Downes M, Lopez-Beltran A, Mckenney J, Narumi Y, Panebianco V, Paner G, Raspollini M, Wojcik E (2022) Invasive urothelial carcinoma. WHO classification of Urinary and Male Genital Tumours, 5th ed, vol 8 Lyon, France: IARC Press.150-165. Williamson S, Al-Ahmadie H, Chang L, Downes M, Lopez-Beltran A, Mckenney J, Narumi Y, Panebianco V, Paner G, Raspollini M, Wojcik E (2022) Invasive urothelial carcinoma. WHO classification of Urinary and Male Genital Tumours, 5th ed, vol 8 Lyon, France: IARC Press.150-165.
28.
go back to reference Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 21(10):2178-2186. https://doi.org/10.1007/s00330-011-2174-7CrossRefPubMed Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 21(10):2178-2186. https://​doi.​org/​10.​1007/​s00330-011-2174-7CrossRefPubMed
29.
go back to reference Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T (2014) Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci. 13(3):175-181. https://doi.org/10.2463/mrms.2013-0104CrossRefPubMed Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T (2014) Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci. 13(3):175-181. https://​doi.​org/​10.​2463/​mrms.​2013-0104CrossRefPubMed
30.
go back to reference Ferro M, Falagario UG, Barone B, Maggi M, Crocetto F, Busetto GM, Giudice FD, Terracciano D, Lucarelli G, Lasorsa F, Catellani M, Brescia A, Mistretta FA, Luzzago S, Piccinelli ML, Vartolomei MD, Jereczek-Fossa BA, Musi G, Montanari E, Cobelli O, Tataru OS (2023) Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement. Diagnostics (Basel). 13(13). https://doi.org/10.3390/diagnostics13132308CrossRef Ferro M, Falagario UG, Barone B, Maggi M, Crocetto F, Busetto GM, Giudice FD, Terracciano D, Lucarelli G, Lasorsa F, Catellani M, Brescia A, Mistretta FA, Luzzago S, Piccinelli ML, Vartolomei MD, Jereczek-Fossa BA, Musi G, Montanari E, Cobelli O, Tataru OS (2023) Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement. Diagnostics (Basel). 13(13). https://​doi.​org/​10.​3390/​diagnostics13132​308CrossRef
31.
go back to reference Akin O, Lema-Dopico A, Paudyal R, Konar AS, Chenevert TL, Malyarenko D, Hadjiiski L, Al-Ahmadie H, Goh AC, Bochner B, Rosenberg J, Schwartz LH, Shukla-Dave A (2023) Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies. Cancers. 15(22):5468.CrossRefPubMedPubMedCentral Akin O, Lema-Dopico A, Paudyal R, Konar AS, Chenevert TL, Malyarenko D, Hadjiiski L, Al-Ahmadie H, Goh AC, Bochner B, Rosenberg J, Schwartz LH, Shukla-Dave A (2023) Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies. Cancers. 15(22):5468.CrossRefPubMedPubMedCentral
Metadata
Title
CT and MRI findings of small cell neuroendocrine carcinoma of the urinary bladder: comparison with urothelial carcinoma
Authors
Masaya Kawaguchi
Hiroki Kato
Takuya Koie
Yoshifumi Noda
Fuminori Hyodo
Tatsuhiko Miyazaki
Masayuki Matsuo
Publication date
08-04-2024
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-024-04274-z
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.